Sign inGet started

Breen Michael Martin

Insider CIK 1863633 · GTBP Executive Chairman/Interim CEO, Director · CRKR Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GTBP GT Biopharma, Inc. A Award deriv2025-09-042025-09-08100,000— $0100,000SEC↗
GTBP GT Biopharma, Inc. A Award deriv2025-09-042025-09-08100,000— $0100,000SEC↗
GTBP GT Biopharma, Inc. A Award deriv2025-09-042025-09-08100,000— $0100,000SEC↗
GTBP GT Biopharma, Inc. A Award2023-08-112023-08-15200,000$0.29 $58.0K856,218SEC↗
CRKR Prairie Operating Co. A Award2023-05-032023-05-05218,571$0.18 $39.3K1,144,683SEC↗
CRKR Prairie Operating Co. P Buy2023-05-032023-05-05916,112$0.11 $100.8K926,112SEC↗
GTBP GT Biopharma, Inc. P Buy2023-04-112023-04-1150,000$0.50 $25.0K656,218SEC↗
GTBP GT Biopharma, Inc. A Award deriv2023-01-272023-02-01500,000— $0500,000SEC↗
GTBP GT Biopharma, Inc. A Award deriv2022-07-152022-07-1950,000— $050,000SEC↗
GTBP GT Biopharma, Inc. A Award2022-07-152022-07-19278,058— $0606,218SEC↗
GTBP GT Biopharma, Inc. C Conversion deriv2021-02-252021-11-12100,000— $00SEC↗
GTBP GT Biopharma, Inc. C Conversion deriv2021-02-252021-11-1230,000— $00SEC↗
GTBP GT Biopharma, Inc. C Conversion2021-02-252021-11-1240,243$3.40 $136.8K318,301SEC↗
GTBP GT Biopharma, Inc. C Conversion2021-02-252021-11-129,859$3.40 $33.5K328,160SEC↗
GTBP GT Biopharma, Inc. A Award deriv2021-02-162021-11-1250,000— $050,000SEC↗
GTBP GT Biopharma, Inc. A Award2021-02-162021-11-12278,058— $0278,058SEC↗
CRKR Prairie Operating Co. A Award deriv2020-08-032023-05-0537,500— $067,500SEC↗
CRKR Prairie Operating Co. A Award deriv2019-09-122023-05-0515,000— $030,000SEC↗
CRKR Prairie Operating Co. A Award deriv2018-10-162023-05-0515,000— $015,000SEC↗